{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:45:43Z","timestamp":1791870343609,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05816-3","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:04:10Z","timestamp":1791867850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting advanced-stage recurrence in resected hepatocellular carcinoma using preoperative gadoxetic acid-enhanced MRI radiomics"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-3194","authenticated-orcid":false,"given":"Jun Gu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-7237","authenticated-orcid":false,"given":"Kyunghwa","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-9531","authenticated-orcid":false,"given":"Leeha","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-1497","authenticated-orcid":false,"given":"Dasom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7759-4458","authenticated-orcid":false,"given":"Hyungjin","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-6274","authenticated-orcid":false,"given":"Jin-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"5816_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","volume":"84","author":"M Reig","year":"2026","unstructured":"Reig M, Sanduzzi-Zamparelli M, Forner A et al (2026) BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update. J Hepatol 84:631\u2013654","journal-title":"J Hepatol"},{"key":"5816_CR2","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M et al (2023) AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78:1922\u20131965","journal-title":"Hepatology"},{"key":"5816_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","volume":"261","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261:947\u2013955","journal-title":"Ann Surg"},{"key":"5816_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.hpb.2021.11.016","volume":"24","author":"ZH Chen","year":"2022","unstructured":"Chen ZH, Zhang XP, Feng JK et al (2022) Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China. HPB (Oxford) 24:1063\u20131073","journal-title":"HPB (Oxford)"},{"key":"5816_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1245\/s10434-009-0330-y","volume":"16","author":"RT Poon","year":"2009","unstructured":"Poon RT (2009) Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies. Ann Surg Oncol 16:792\u2013794","journal-title":"Ann Surg Oncol"},{"key":"5816_CR6","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/liv.15363","volume":"42","author":"LN Qi","year":"2022","unstructured":"Qi LN, Ma L, Wu FX et al (2022) Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study. Liver Int 42:2283\u20132298","journal-title":"Liver Int"},{"key":"5816_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"key":"5816_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jhep.2024.06.018","volume":"81","author":"C Fuster-Anglada","year":"2024","unstructured":"Fuster-Anglada C, Mauro E, Ferrer-F\u00e0brega J et al (2024) Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. J Hepatol 81:995\u20131004","journal-title":"J Hepatol"},{"key":"5816_CR9","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1111\/liv.15719","volume":"43","author":"F Pelizzaro","year":"2023","unstructured":"Pelizzaro F, Trevisani F, Simeon V et al (2023) Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection. Liver Int 43:2762\u20132775","journal-title":"Liver Int"},{"key":"5816_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.21037\/hbsn-2025-45","volume":"14","author":"DI Tsilimigras","year":"2025","unstructured":"Tsilimigras DI, Ntanasis-Stathopoulos I, Moris D (2025) Recurrence beyond Milan criteria following liver resection for early-stage hepatocellular carcinoma: incidence, prediction and implications for treatment selection. Hepatobiliary Surg Nutr 14:305\u2013307","journal-title":"Hepatobiliary Surg Nutr"},{"key":"5816_CR11","doi-asserted-by":"crossref","unstructured":"Hsu HY, Tang JH, Huang SF et al (2024) Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular Carcinoma. Biomedicines 12","DOI":"10.3390\/biomedicines12030655"},{"key":"5816_CR12","doi-asserted-by":"publisher","first-page":"e230527","DOI":"10.1148\/radiol.230527","volume":"309","author":"H Jiang","year":"2023","unstructured":"Jiang H, Yang C, Chen Y et al (2023) Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection. Radiology 309:e230527","journal-title":"Radiology"},{"key":"5816_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the L","year":"2025","unstructured":"European Association for the Study of the L (2025) EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol 82:315\u2013374","journal-title":"J Hepatol"},{"key":"5816_CR14","first-page":"1","volume":"23","author":"A Korean Liver Cancer","year":"2023","unstructured":"Korean Liver Cancer A, National Cancer Center K (2023) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. J Liver Cancer 23:1\u2013120","journal-title":"J Liver Cancer"},{"key":"5816_CR15","doi-asserted-by":"crossref","unstructured":"Singal AG, Yarchoan M, Yopp A, Sapisochin G, Pinato DJ, Pillai A (2024) Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun 8","DOI":"10.1097\/HC9.0000000000000430"},{"key":"5816_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","volume":"11","author":"JE van Timmeren","year":"2020","unstructured":"van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B (2020) Radiomics in medical imaging-\u201chow-to\u201d guide and critical reflection. Insights Imaging 11:91","journal-title":"Insights Imaging"},{"key":"5816_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.acra.2023.09.008","volume":"31","author":"J Jin","year":"2024","unstructured":"Jin J, Jiang Y, Zhao YL, Huang PT (2024) Radiomics-based Machine Learning to Predict the Recurrence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Acad Radiol 31:467\u2013479","journal-title":"Acad Radiol"},{"key":"5816_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","volume":"14","author":"B Kocak","year":"2023","unstructured":"Kocak B, Baessler B, Bakas S et al (2023) CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII. Insights Imaging 14:75","journal-title":"Insights Imaging"},{"key":"5816_CR19","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1158\/1078-0432.CCR-18-2861","volume":"25","author":"S Kim","year":"2019","unstructured":"Kim S, Shin J, Kim DY, Choi GH, Kim MJ, Choi JY (2019) Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma. Clin Cancer Res 25:3847\u20133855","journal-title":"Clin Cancer Res"},{"key":"5816_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/2532051","volume":"45","author":"LI Lin","year":"1989","unstructured":"Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255\u2013268","journal-title":"Biometrics"},{"key":"5816_CR21","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s00261-025-05184-4","volume":"51","author":"ST Maung","year":"2026","unstructured":"Maung ST, Tangkijvanich P, Chaiteerakij R (2026) Magnetic resonance imaging radiomics for predicting hepatocellular carcinoma recurrence following resection or ablation: a systematic review and meta-analysis. Abdom Radiol (NY) 51:1834\u20131853","journal-title":"Abdom Radiol (NY)"},{"key":"5816_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2026.01.006","author":"A Yopp","year":"2026","unstructured":"Yopp A, Chen M, Cheng AL et al (2026) Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2026.01.006","journal-title":"J Hepatol"},{"key":"5816_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1200\/JCO.2026.44.2_suppl.477","volume":"44","author":"SL Chan","year":"2026","unstructured":"Chan SL, Bouattour M, Yau T et al (2026) Adjuvant pembrolizumab for participants with hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation: The phase 3 keynote-937 study. Journal of Clinical Oncology 44:477\u2013477","journal-title":"Journal of Clinical Oncology"},{"key":"5816_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41698-025-00846-4","volume":"9","author":"V Akula","year":"2025","unstructured":"Akula V, Chen L, Acikgoz Y et al (2025) Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma. NPJ Precis Oncol 9:60","journal-title":"NPJ Precis Oncol"},{"key":"5816_CR25","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1158\/1078-0432.CCR-18-2641","volume":"25","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Hoefsmit EP, Smyth MJ, Blank CU, Teng MWL (2019) The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment. Clin Cancer Res 25:5743\u20135751","journal-title":"Clin Cancer Res"},{"key":"5816_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","volume":"21","author":"JM Llovet","year":"2024","unstructured":"Llovet JM, Pinyol R, Yarchoan M et al (2024) Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nat Rev Clin Oncol 21:294\u2013311","journal-title":"Nat Rev Clin Oncol"},{"key":"5816_CR27","doi-asserted-by":"publisher","first-page":"106609","DOI":"10.1016\/j.cmpb.2021.106609","volume":"215","author":"A Abbasian Ardakani","year":"2022","unstructured":"Abbasian Ardakani A, Bureau NJ, Ciaccio EJ, Acharya UR (2022) Interpretation of radiomics features-A pictorial review. Comput Methods Programs Biomed 215:106609","journal-title":"Comput Methods Programs Biomed"},{"key":"5816_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","volume":"67","author":"S Lee","year":"2017","unstructured":"Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526\u2013534","journal-title":"J Hepatol"},{"key":"5816_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13244-022-01354-w","volume":"14","author":"T Yang","year":"2023","unstructured":"Yang T, Wei H, Wu Y et al (2023) Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5\u00a0cm on gadoxetate disodium-enhanced MRI. Insights Imaging 14:3","journal-title":"Insights Imaging"},{"key":"5816_CR30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3348\/kjr.2018.0070","volume":"20","author":"JE Park","year":"2019","unstructured":"Park JE, Park SY, Kim HJ, Kim HS (2019) Reproducibility and Generalizability in Radiomics Modeling: Possible Strategies in Radiologic and Statistical Perspectives. Korean J Radiol 20:1124\u20131137","journal-title":"Korean J Radiol"},{"key":"5816_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology 295:328\u2013338","journal-title":"Radiology"},{"key":"5816_CR32","unstructured":"Zwanenburg A, Leger S, Valli\u00e8res M, L\u00f6ck S (2016) Image biomarker standardisation initiative. arXiv preprint arXiv:161207003"},{"key":"5816_CR33","doi-asserted-by":"crossref","unstructured":"Zhang P, Shi Y, Zhou M et al (2025) A CECT-Based Radiomics Nomogram Predicts the Overall Survival of Patients with Hepatocellular Carcinoma After Surgical Resection. Biomedicines 13","DOI":"10.3390\/biomedicines13051237"},{"key":"5816_CR34","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/jmri.28725","volume":"58","author":"X Cao","year":"2023","unstructured":"Cao X, Yang H, Luo X et al (2023) A Cox Nomogram for Assessing Recurrence Free Survival in Hepatocellular Carcinoma Following Surgical Resection Using Dynamic Contrast-Enhanced MRI Radiomics. J Magn Reson Imaging 58:1930\u20131941","journal-title":"J Magn Reson Imaging"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05816-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:04:12Z","timestamp":1791867852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05816-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":34,"alternative-id":["5816"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05816-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"16 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hyungjin Rhee has received research grant from Central Medical Service, as well as honoria, travel, and accommodation expenses from Bayer. The funders of this study played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}